Pfizer and BioNTech are asking the FDA for full approval of their COVID vaccine.
If the agency gives it the greenlight it would be the first vaccine in the U.S. to have complete approval.
The vaccines that have been approved already were all given emergency use authorization. That's a distinction that's used during public health emergencies.
The FDA is expected to take weeks to review the application.
